Enlivex Therapeutics Ltd. (ENLV)
1.01
0.06 (6.32%)
At close: Apr 02, 2025, 3:59 PM
0.96
-5.23%
After-hours: Apr 02, 2025, 07:32 PM EDT
Enlivex Therapeutics Ltd. Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 813K | 47.82M | 11.2M | 5.67M | 3.95M | 9.74M | 3.53M | 6.87M | 7.29M | 10.58M | 5.55M | 146K |
| Short-Term Investments | 26.51M | 299K | 72.93M | 30.03M | 8.06M | 40K | n/a | 3.01M | 12.05M | 22.03M | n/a | n/a |
| Long-Term Investments | 308K | 307K | 3K | 89K | 76K | 56K | n/a | 11K | 33K | n/a | n/a | n/a |
| Other Long-Term Assets | 179K | 105K | 482K | 8K | -329K | 16K | 38.00 | 7K | n/a | 9K | 5K | n/a |
| Receivables | n/a | n/a | 1.09M | n/a | -1.1M | 213K | n/a | 52K | 145K | 93K | 26K | 10K |
| Inventory | n/a | 1.18M | -12.2M | -31.2M | 1.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 5.34M | n/a | 1.2M | 1.17M | 3.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 33.76M | 52.33M | 86.44M | 38.12M | 16.42M | 10.28M | 3.62M | 10.54M | 20.39M | 32.88M | 5.68M | 156K |
| Property-Plant & Equipment | 2.58M | 14.9M | 8.22M | 2.14M | 1.06M | 685K | 388.00 | 71K | 91K | 60K | 2K | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | 410K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 3.07M | 15.31M | 8.7M | 2.24M | 1.14M | 757K | 426.00 | 89K | 124K | 69K | 7K | n/a |
| Total Assets | 36.83M | 67.64M | 95.15M | 40.36M | 17.56M | 11.03M | 3.62M | 10.63M | 20.52M | 32.95M | 5.69M | 156K |
| Account Payables | 827K | 1.95M | 878K | 463K | 316K | 173K | 19K | 32K | 1.41M | 1.28M | 46K | 74K |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 1.23M | n/a | n/a | 1.17M | 3.4M | n/a | 403K | 1.5M | 639K | n/a | 59K | n/a |
| Total Current Liabilities | 6.06M | 6.61M | 4.72M | 4.37M | 5.98M | 1.13M | 460K | 1.93M | 2.51M | 2.28M | 131K | 81K |
| Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | 499K | n/a | 198K | n/a | n/a | 70K | n/a | n/a | n/a |
| Total Long-Term Liabilities | 686K | 4.19M | 5.39M | 499K | 298K | 198K | n/a | n/a | 70K | n/a | n/a | n/a |
| Total Liabilities | 6.75M | 10.8M | 10.11M | 4.87M | 6.28M | 1.33M | 460K | 1.93M | 2.58M | 2.28M | 131K | 81K |
| Total Debt | 1.03M | 4.85M | 617K | 203K | 123K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 2.14M | 2.12M | 2.11M | 1.65M | 1.15M | 396K | 45K | 45K | 39K | 39K | 29K | 20K |
| Retained Earnings | -112.09M | -83.03M | -51.97M | -37.5M | -25.67M | -16.29M | -45.75M | -39.81M | -23.79M | -8.42M | -1.4M | -229K |
| Comprehensive Income | 1.1M | 1.1M | 1.1M | 977K | -1.3M | -2.25M | -1.5K | -40K | -22K | -5K | n/a | n/a |
| Shareholders Equity | 30.08M | 56.84M | 85.04M | 35.49M | 11.28M | 9.71M | 3.16M | 8.7M | 17.93M | 30.67M | 5.55M | 75K |
| Total Investments | 26.82M | 299K | 72.93M | 30.03M | 8.06M | 40K | n/a | 3.02M | 12.08M | 22.03M | n/a | n/a |